Biobanks work at the interface between patient care and biomedical research. They collect patients’ sample material that is no longer needed after diagnosis and is otherwise discarded. The biobank processes these residual materials such as body fluids or tissue and stores the biosamples under high quality standards until they are used in research projects. To ensure that the biomaterials can be precisely selected for studies and other research projects, clinical data such as age, gender, diagnosis and therapeutic procedures are also collected and documented for each patient and passed on to research in encrypted form.
Latest News
The bacteria in house dust make the difference - what constitutes the farm effect?
Allergic diseases have become widespread diseases in recent decades due to the dramatic increase in the number of new cases. This trend is…
Vier neue Partner für die German Biobank Alliance (GBA)
Die Comprehensive Biomaterial Bank Marburg (CBBMR), die Marburger Biobank am Fachbereich Medizin der Philipps-Universität Marburg ist Teil des…
Continuously grown
Ethics vote for the establishment of an organoid bank pancreatic tumor
The Marburg biobank is setting up a cell culture laboratory for the production of organoids
Start collecting control blood
The biobank is being expanded with the provision of normal blood samples from voluntary healthy donors
Start of the module expansion "Childhood Tumors"
The tumor bank is expanded to include childhood tumor diseases
Launch of the module "SynChron- Chronic inflammatory diseases"
The Marburg Biobank collects tissue and blood samples for the investigation of autoimmune diseases and allergies.
Certification Quality Management
The quality management of the CBBMR was today certified by the TÜV SÜD Management Service GmbH according to DIN EN ISO 9001:2015.
You can find further details under QM.
Marburg biobank laboratory opened
The Marburg biobank will have its own biobank laboratory
Starting shot for the tumor biobank
Now that all planning and preliminary work has been successfully completed, Module 1 "Tumor Diseases" is going into productive operation today.